Healthy men help track leukemia Drug's path
NCT ID NCT06986772
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study looked at how a drug called TGRX-678, used for chronic myeloid leukemia, is absorbed, broken down, and removed from the body. Six healthy men took a single radioactive dose so researchers could measure the drug in their blood, urine, and stool. The goal was not to treat disease, but to understand the drug's journey to help guide future dosing and safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
Conditions
Explore the condition pages connected to this study.